Microchip Technology (MCHP) rose 2.6% to $78.10 on November 3, 2026, two days before earnings. The bounce sits inside a weekly downtrend: the shares are below their 40-week average and just under the 200-day average at $79.73. The balance of evidence is even, with low conviction. MCHP has outrun both the S&P 500 and the chip sector over 50 days, but that strength is working against the trend, and the November 5 report is the next test.
Why it matters
The event is the quarterly report due after the close on November 5. Options pricing points to a move of about 6.9% either way, according to Investing.com, and the stock has exceeded its implied move in six of the past eight reports. A swing of that size is wider than the distance from today's price to either the $75.61 support or the $81.51 resistance. The report can therefore settle the near-term direction on its own.
The stock's recent moves have come from the sector rather than from company news. On October 27 MCHP gained 3.9% alongside Intel, Marvell and onsemi after Broadcom's reported $63 billion financing for custom AI chips, as Yahoo! Finance reported. The next day, NASDAQ noted that chip stocks supported the market after SK Hynix said its memory is sold out through 2029, even as the Fed held rates with two officials dissenting in favor of a hike. MCHP's own product announcements, in space computing, timing and FPGA networking, were routine and do not explain any price move.
Over the past five days the stock fell 3.4%, the S&P 500 (via SPY) fell 2.1%, and the semiconductor group (SOXX) fell 9.4%. MCHP therefore beat its sector by about 6 points, and nearly all of its drop came from the market and the sector. SOXX is down 21.4% over a month yet still up 53.7% this year, and the supplied news does not explain that sharp sector slide. Today's 2.6% gain closely matched SOXX's 2.4%, but it came on volume about 47% below the 20-day average. A rebound on thin trading is a weak confirmation.
The argument about MCHP is estimates against price. The optimistic side has real numbers: Yahoo! Finance reported a Zacks Rank #2 upgrade, with the consensus estimate up 18.3% over three months to $3.67 a share for the fiscal year ending March 2027. A separate Yahoo! Finance piece showed a $110.04 mean target from 25 analysts, implying 49% upside from $73.85, while cautioning against leaning on price targets. The cautious side points to the chart: the market has not paid for those estimates, with the shares 24% below the 52-week high of $102.92 and down 17.6% over six months. Today's mean target is $105.92, which leaves the price 26.3% below it. Targets run from $75 to $135, so the stock sits barely above the lowest one, and the mean has slipped since October 19. The consensus rating remains buy.
What the evidence says
On the long term, the thesis is weakened, not broken. The stock is up 21.5% this year and 59% above its 52-week low of $49.02. But it is below its 40-week average and about 4% under its October 5 closing peak of $81.49, and the weekly trend is down. The phase is a repair attempt: the shares are back above the 10-week and 50-day averages ($75.34) but have not reclaimed the longer ones.
For the next 2 to 6 weeks, the balance of evidence is even, and conviction is low at 0 of 4. The rally against the weekly downtrend is not yet stretched, with RSI near 64. MCHP leads the S&P 500 by 5.5 points and SOXX by 17.2 points over 50 days. But each of those strengths runs against the trend, so none of the four tests of agreement lines up. The strongest case against an even reading is a negative one. The stock sits just under the 200-day average, where sellers have appeared on rallies, the bounce came on light volume, and a sector down 21% in a month can pull a relative winner lower. That case does not tip the balance because MCHP has absorbed the sector's drop far better than its peers and still holds above the 50-day average. It is, however, the reason conviction is not higher.
Levels that matter
With the weekly trend down, the structure holds below $79.73, the 200-day average, which is where sellers have shown up on rallies. The trend would end above $81.51, a swing zone that sits just over the October 5 peak of $81.49. Beyond it lie further resistance at $83.38, $85.62 and the $90 round number. Below the price, support begins at $75.61, with the 50-day average at $75.34 right beneath it.
The breakout math points down. A daily close below $75.61 opens the way to $68.42 and then $63.54, with $70 in between as a round-number pause. The move would be wrong above $80.62, which is the 200-day average plus a quarter of the 14-day average range. From $75.61 that gives 1.4 to 1 at the first target and 2.4 to 1 at the second, short of the 3 to 1 that makes a breakout worth the risk. Reaching 3 to 1 would take a lower target or a tighter stop.
What would change the picture
A weekly close above $81.51 would end the downtrend reading and make the rally a trend change instead of a bounce. The non-price fact that could produce it is an earnings report whose guidance supports the 18.3% rise in estimates, because that would give buyers a fundamental reason to pay up through the 200-day average.
What to watch
- Earnings, November 5, after the close: the number that matters is next-quarter revenue guidance against the consensus behind the $3.67 fiscal-year estimate. Options imply a move of about 6.9%.
- Sector first: SOXX fell 9.4% in five days, and headlines from SK Hynix, Broadcom and the Fed moved MCHP before its own news did.
- Valuation: at $78.10 the stock is 26.3% below the $105.92 mean target, with analyst targets spanning $75 to $135.